Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Quick Stats
Feb 02, 202646.0
AI Score
HOLD0.78
Volume Ratio
Mar 19, 2026
Next Earnings
13
+ve Days (30d)
16
-ve Days (30d)
CGTX Stock Summary
Last updated Feb 02, 2026
CGTX is currently trading at $1.14, positioned below its 200-day moving average of $1.19, suggesting bearish momentum. The stock has a 52-week range of $0.2223 to $3.83.
Technical Analysis: The 50-day moving average stands at $1.48, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 33.549, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.25, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CGTX at 46.0/100 with a HOLD recommendation.
CGTX (Cognition Therapeutics, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 33.549 |
| CMF (20) | -0.25 |
| ROC (10) | -21.918 |
| ADX (14) | 14.852 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.083 |
| AROONOSC (14) | -64.286 |
| WILLAMS %R (14) | -85.057 |
| MFI (14) | 20.539 |
CGTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CGTX Price vs Max Options Open Interest
CGTX Max Change In Options Open Interest
CGTX Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CGTX Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CGTX Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CGTX Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Cognition Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CGTX Moving Averages Analysis
CGTX (Cognition Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 1.31 |
| 20 | 1.37 |
| 30 | 1.4 |
| 50 | 1.48 |
| 100 | 1.57 |
| 200 | 1.19 |
CGTX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 96.2 million |
| Earnings/Share ($) | -0.47 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.39 |
| EPS Estimate Next Year ($) | -0.335 |
| WallStreet Target Price ($) | 3.5 |
| Most Recent Quarter |
The news related to $CGTX is that the company is recovering after a direct offering and rescheduling a meeting. They are deepening their due diligence for the next 6 months and have examples of 6-month Phase 3 trials. The stock is holding up well above $2.50 and is predicted to reach $4 soon. Investors are advised to wait to buy back after the market opens to potentially get more shares. There are concerns about short sellers driving the stock down, but overall the future looks promising for the company.
Updated 2025-08-28 09:00:03